🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Socioeconomic Gradients in Mortality Following HF Hospitalization in a Country With Universal Health Care Coverage jacc.org/doi/10.1016/j.…

Ready for the new #ESCCardioTalk episode?😀 Secondary tricuspid regurgitation: neglected no more! Philipp E. Bartko , Gregor Heitzinger and Georg Goliasch discuss the use of quantitative echocardiography parameters to grade TR bit.ly/3buqo1e EHJ Editor-in-Chief #EHJ #cardiotwitter #MedTwitter

#3Decho allowing to quantify the regurgitant fraction might improve the way we will assess the FTR severity in future trials and in clinical practice. Very nice podcast putting our study in perspective by Philipp E. Bartko Gregor Heitzinger Georg Goliasch. Congratulations & thank you! #EHJCVI

Secondary tricuspid regurgitation? Neglected no more! Philipp E. Bartko, Georg Goliasch and Gregor Heitzinger from Kardiologie MedUni Wien Forschung Structural Heart Vienna discuss this important topic in the newest European Society of Cardiology #ESCCardioTalk - Congratulations! bit.ly/3buqo1e

#Valve-in-Ring - a valuable tool for recurrent #tricuspid regurgitation due to #annuloplasty failure! #ViR #vhdTR #tricuspidregurgitation Georg Goliasch Philipp E. Bartko Structural Heart Vienna Max-Paul Winter @CHengstenbergMD Varius Dannenberg Matthias Koschutnik

RTHahnMD American College of Cardiology European Society of Cardiology Philipp Lurz Azeem Latib Columbia Valve Center Maurizio taramasso Totally agree, TRIsCEND II has German BfArM approval

Transcatheter treatment by valve-in-valve and valve-in-ring implantation for prosthetic tricuspid valve dysfunction - an educational review by our Structural Heart Vienna group link.springer.com/article/10.100…

#EuroPCR Today PCR Tricuspid Focus Group was introduced. The Focus Group is committed to fostering the establishment of tricuspid therapies, improving outcomes & delivering sustainable clinical. pcronline.com/Network/Tricus… PCRonline 🫀 #treatTR #fixTR #PCRtricuspid

The tricuspid team! Full afternoon exchanging great tips and tricks! EuroPCR@Lisbon - second day! #EuroPCR #EuroPCR2021 APIC Sociedade Portuguesa de Cardiologia Giulio Stefanini ruicteles cardio EAPCIPresident @RitaCal3 Pedro de Araujo Goncalves brmelica @CarlosGalvoBra1 Joana Delgado Silva #YoungEAPCI

Live interactive #cardioed continues even post-#EuroPCR with the 3rd free webinar in the series on transcatheter management of mitral and TR! Join us for "How to use #TMVR to treat patients with mitral regurgitation" on Wed 2 June 5pm Paris 🕔 ow.ly/Tmvf30rIqvD

I write a little bit better but great quote , agree ? 🤔 David H. Wiener, MD Nicolas Merke Prof Derek Connolly Ajay Kirtane Benoy Shah MD Mamas A. Mamas Rahat Warraich PhD Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 sema güneri Dr Meral Kayikcioglu Giuseppe Galati Ritu Thamman MD Dr Yane Valdez Tejeira @fitmslax Ana Catarina Angioplasty.Org

Can you name the defect here? 🍀 #Echofirst #Echocardiography

RV perforation is a concern during tricuspid interventions. In this case we increased patient safety by placing the super stiff wire in the pulmonary artery and not in the apex (SAPIEN S3 29 in Hancock 31). Amit Segev PCRonline 🫀 Mack Eleid Philipp Lurz Maurizio taramasso #TAVR

Excellent result of a mitral valve-in-valve procedure! Structural Heart Vienna Konstantin Krychtiuk Interventional Cardiology MedUniVienna @CHengstenbergMD Philipp E. Bartko Georg Goliasch Andreas Kammerlander Christian Nitsche Matthias Koschutnik Gregor Heitzinger

Guess the thickness of the walls?

Case of a massiv TR, solved with 2 anteroseptal XTR Clips. Very happy with only trace residual TR :) #echofirst #CVimaging Structural Heart Vienna Konstantin Krychtiuk Interventional Cardiology MedUniVienna @CHengstenbergMD Philipp E. Bartko Georg Goliasch Andreas Kammerlander Christian Nitsche Matthias Koschutnik Gregor Heitzinger